Q-linea AB (publ)

OM:QLINEA Stock Report

Market Cap: SEK 40.2m

Q-linea Valuation

Is QLINEA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of QLINEA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate QLINEA's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate QLINEA's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for QLINEA?

Key metric: As QLINEA is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for QLINEA. This is calculated by dividing QLINEA's market cap by their current revenue.
What is QLINEA's PS Ratio?
PS Ratio10.7x
SalesSEK 3.50m
Market CapSEK 40.19m

Price to Sales Ratio vs Peers

How does QLINEA's PS Ratio compare to its peers?

The above table shows the PS ratio for QLINEA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average11.3x
ALTE Alteco Medical
9.1xn/aSEK 26.8m
SDET SensoDetect Aktiebolag
15.8xn/aSEK 35.7m
PERP B Perpetua Medical
5xn/aSEK 27.1m
FLUI Fluicell
15.4xn/aSEK 24.7m
QLINEA Q-linea
10.7x51.1%SEK 40.2m

Price-To-Sales vs Peers: QLINEA is good value based on its Price-To-Sales Ratio (10.7x) compared to the peer average (11.3x).

Price to Sales Ratio vs Industry

How does QLINEA's PS Ratio compare vs other companies in the SE Medical Equipment Industry?

12 CompaniesPrice / SalesEstimated GrowthMarket Cap
ARJO B Arjo
0.9x4.0%US$922.65m
CARE Careium
0.8x10.2%US$63.47m
ADDV A ADDvise Group
0.8x9.2%US$52.12m
BOUL Boule Diagnostics
0.6x6.2%US$34.95m
QLINEA 10.7xIndustry Avg. 5.1xNo. of Companies12PS048121620+
12 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: QLINEA is expensive based on its Price-To-Sales Ratio (10.7x) compared to the Swedish Medical Equipment industry average (5.1x).

Price to Sales Ratio vs Fair Ratio

What is QLINEA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

QLINEA PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio10.7x
Fair PS Ratio0.1x

Price-To-Sales vs Fair Ratio: QLINEA is expensive based on its Price-To-Sales Ratio (10.7x) compared to the estimated Fair Price-To-Sales Ratio (0.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst QLINEA forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentSEK 0.32
SEK 7.00
+2,084.1%
57.1%SEK 11.00SEK 3.00n/a2
Jan ’26SEK 0.69
SEK 7.00
+914.5%
57.1%SEK 11.00SEK 3.00n/a2
Dec ’25SEK 1.18
SEK 7.00
+493.2%
57.1%SEK 11.00SEK 3.00n/a2
Nov ’25SEK 2.47
SEK 8.50
+244.1%
29.4%SEK 11.00SEK 6.00n/a2
Oct ’25SEK 2.83
SEK 8.50
+200.9%
29.4%SEK 11.00SEK 6.00n/a2
Sep ’25SEK 3.77
SEK 8.50
+125.5%
29.4%SEK 11.00SEK 6.00n/a2
Aug ’25SEK 3.47
SEK 8.50
+145.0%
29.4%SEK 11.00SEK 6.00n/a2
Jul ’25SEK 3.96
SEK 8.50
+114.9%
29.4%SEK 11.00SEK 6.00n/a2
Jun ’25SEK 2.44
SEK 8.50
+248.4%
29.4%SEK 11.00SEK 6.00n/a2
May ’25SEK 2.60
SEK 8.50
+227.6%
29.4%SEK 11.00SEK 6.00n/a2
Apr ’25SEK 2.14
SEK 8.50
+297.2%
29.4%SEK 11.00SEK 6.00n/a2
Mar ’25SEK 2.11
SEK 10.00
+373.9%
10.0%SEK 11.00SEK 9.00n/a2
Feb ’25SEK 3.24
SEK 10.00
+208.6%
10.0%SEK 11.00SEK 9.00n/a2
Jan ’25SEK 3.70
SEK 10.00
+170.3%
10.0%SEK 11.00SEK 9.00SEK 0.692
Dec ’24SEK 2.80
SEK 10.00
+257.1%
10.0%SEK 11.00SEK 9.00SEK 1.182
Jul ’24SEK 2.89
SEK 11.50
+297.9%
4.3%SEK 12.00SEK 11.00SEK 3.962
Jun ’24SEK 3.49
SEK 28.50
+716.6%
57.9%SEK 45.00SEK 12.00SEK 2.442
May ’24SEK 4.43
SEK 30.50
+588.5%
47.5%SEK 45.00SEK 16.00SEK 2.602
Apr ’24SEK 6.95
SEK 30.50
+338.8%
47.5%SEK 45.00SEK 16.00SEK 2.142
Analyst Price Target
Consensus Narrative from 2 Analysts
SEK 7.00
Fair Value
95.4% undervalued intrinsic discount
2
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/22 22:33
End of Day Share Price 2025/01/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Q-linea AB (publ) is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Ulrik TrattnerCarnegie Investment Bank AB
Alexandru CogutKempen & Co. NV